These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10975587)

  • 81. [Prediction of restenosis after percutaneous transluminal coronary angioplasty using coronary flow reserve. Kansai Doppler Guide Wire Study Group].
    Toda I; Teragaki M; Nishida Y; Kobayashi Y; Shimada K; Yoshiyama M; Akioka K; Takeuchi K; Yoshikawa J
    J Cardiol; 2000 Mar; 35(3):165-73. PubMed ID: 10808423
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Progression of coronary artery disease in patients receiving percutaneous transluminal coronary angioplasty: angiographic comparison of angioplasty and non-angioplasty sites.
    Ohtani R; Hiasa Y
    Intern Med; 1995 Jul; 34(7):611-7. PubMed ID: 7496068
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Effects of ketanserin on epicardial coronary arteries after coronary angioplasty in patients with stable angina.
    Tousoulis D; Davies G; Tentolouris C; Apostolopoulos T; Kyriakides M; Toutouzas P
    Eur Heart J; 1994 Jul; 15(7):922-7. PubMed ID: 7925513
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Randomized trial of late elective angioplasty versus conservative management for patients with residual stenoses after thrombolytic treatment of myocardial infarction. Treatment of Post-Thrombolytic Stenoses (TOPS) Study Group.
    Ellis SG; Mooney MR; George BS; da Silva EE; Talley JD; Flanagan WH; Topol EJ
    Circulation; 1992 Nov; 86(5):1400-6. PubMed ID: 1423952
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Effect of doxazosin on arterial elasticity: functional versus structural changes.
    Bratteli CW; Glasser SP
    J Clin Pharmacol; 2002 Oct; 42(10):1105-8. PubMed ID: 12362924
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Parameters of cell energy metabolism during stress in laboratory animals and energotropic effect of alpha1-adrenoblocker doxazosin.
    Vishnevskii EL; Vishnevskii AE; Shabel'nikova EI; Safronova ON; Dreval AA; Topchieva GV; Sukhorukov VS
    Bull Exp Biol Med; 2004 Nov; 138(5):440-1. PubMed ID: 15723120
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade.
    Bairey Merz CN; Pepine CJ; Walsh MN; Fleg JL
    Circulation; 2017 Mar; 135(11):1075-1092. PubMed ID: 28289007
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Fractional flow reserve-guided percutaneous coronary intervention: does coronary pressure never lie?
    van de Hoef TP; van Lavieren MA; Henriques JP; Piek JJ; Claessen BE
    Curr Treat Options Cardiovasc Med; 2014 Apr; 16(4):294. PubMed ID: 24515354
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Fractional flow reserve as a surrogate for inducible myocardial ischaemia.
    van de Hoef TP; Meuwissen M; Escaned J; Davies JE; Siebes M; Spaan JA; Piek JJ
    Nat Rev Cardiol; 2013 Aug; 10(8):439-52. PubMed ID: 23752699
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Dobutamine-induced hyperaemia inversely correlates with coronary artery stenosis severity and highlights dissociation between myocardial blood flow and oxygen consumption.
    Jagathesan R; Barnes E; Rosen SD; Foale R; Camici PG
    Heart; 2006 Sep; 92(9):1230-7. PubMed ID: 16547210
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Positron emission tomography for quantitation of myocardial perfusion.
    Rimoldi OE; Camici PG
    J Nucl Cardiol; 2004; 11(4):482-90. PubMed ID: 15295417
    [No Abstract]   [Full Text] [Related]  

  • 92. Myocardial viability, coronary flow reserve, and in-hospital predictors of late recovery of contractility following successful primary stenting for acute myocardial infarction.
    Beygui F; Le Feuvre C; Helft G; Maunoury C; Metzger JP
    Heart; 2003 Feb; 89(2):179-83. PubMed ID: 12527673
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Coronary vasoconstriction after percutaneous transluminal coronary angioplasty is attenuated by antiadrenergic agents.
    Gregorini L; Fajadet J; Robert G; Cassagneau B; Bernis M; Marco J
    Circulation; 1994 Aug; 90(2):895-907. PubMed ID: 8044961
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Delayed recovery of coronary resistive vessel function after coronary angioplasty.
    Uren NG; Crake T; Lefroy DC; de Silva R; Davies GJ; Maseri A
    J Am Coll Cardiol; 1993 Mar; 21(3):612-21. PubMed ID: 8436742
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Limitation of coronary reserve after successful angioplasty is prevented by oral pretreatment with an alpha1-adrenergic antagonist.
    Rimoldi O; Spyrou N; Foale R; Hackett DR; Gregorini L; Camici PG
    J Cardiovasc Pharmacol; 2000 Sep; 36(3):310-5. PubMed ID: 10975587
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Adrenergically mediated coronary vasoconstriction in patients with syndrome X.
    Camici PG; Marraccini P; Gistri R; Salvadori PA; Sorace O; L'Abbate A
    Cardiovasc Drugs Ther; 1994 Apr; 8(2):221-6. PubMed ID: 7918134
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Effect of alpha1-adrenoceptor blockade on coronary vasodilator reserve in cardiac syndrome X.
    Rosen SD; Lorenzoni R; Kaski JC; Foale RA; Camici PG
    J Cardiovasc Pharmacol; 1999 Oct; 34(4):554-60. PubMed ID: 10511131
    [TBL] [Abstract][Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.